It has been well-established that EZH2 promotes cell survival, proliferation, epithelial-mesenchymal transition, invasion and drug resistance of cancer cells through downregulation of tumor suppressor genes expression and oncogenes upregulation [28]. This evidence concerns the gene EZH2 and cancer.